Non-surgical left atrial appendage closure for stroke prevention in atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 22, Issue 10, 2011, Pages 1184-1191

  Friedman, Paul A ^a   Holmes, David R ^a  

^a MAYO CLINIC   (United States)

Author keywords

atrial fibrillation; LAA occlusion; left atrial appendage; stroke; WATCHMAN

Indexed keywords

WARFARIN;

ABLATION THERAPY; AIR EMBOLISM; ANTICOAGULATION; BLEEDING; BLOOD FLOW; CARDIAC PATIENT; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ELECTRIC ACTIVITY; ELECTROGRAPHY; EMBOLIC PROTECTION DEVICE; FOOD DRUG INTERACTION; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART INFARCTION; HUMAN; MULTICENTER STUDY (TOPIC); PHYSICIAN; PLAATO; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STROKE; THROMBOEMBOLISM; WATCHMAN;

ANTICOAGULANTS; ATRIAL APPENDAGE; ATRIAL FIBRILLATION; HEART CATHETERIZATION; HEMORRHAGE; HUMANS; PATIENT SELECTION; RISK ASSESSMENT; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 80054752832     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02172.x     Document Type: Review

References (38)

1. Chugh S, Blackshear JL, Shen W-K, Hammill S, Gersh BJ,: Epidemiology and natural history of atrial fibrillation: Clinical problems. J Am Coll Cardiol 2001; 37: 371-378.
2. Miyasaka Y, Barnes M, Gersh BJ, Cha S, Bailey K, Abhayaratna W, Seward JB, Tsang T,: Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-125. (Pubitemid 44420743)
3. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE,: Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. JAMA 2001; 285: 2370-2375. (Pubitemid 32424106)
4. Blackshear JL, Odell JA,: Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg 1996; 61: 755-759. (Pubitemid 26060923)
5. Blackshear JL, Johnson WD, Odell JA, Baker VS, Howard M, Pearce L, Stone C, Packer DL, Schaff HV,: Thoracoscopic extracardiac obliteration of the left atrial appendage for stroke risk reduction in atrial fibrillation. [see comment]. J Am Coll Cardiol 2003; 42: 1249-1252. (Pubitemid 37188351)
6. Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH,: Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
7. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL,: ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: Full text: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006; 8: 651-745. (Pubitemid 44472247)
8. Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, Buchbinder M, Mullin CM, Sick P,: Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial. Lancet 2009; 374: 534-542.
9. Singh IM, Holmes DR Jr,: Left atrial appendage closure. Curr Cardiol Rep 2010; 12: 413-421.
10. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L,: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
11. Lip GY, Blann AD,: Atrial fibrillation and abnormalities of hemostatic factors. Am J Cardiol 2001; 87: 1136-1137. (Pubitemid 32710339)
12. Chung MK, Martin DO, Sprecher D, Wazni O, Kanderian A, Carnes CA, Bauer JA, Tchou PJ, Niebauer MJ, Natale A, Van Wagoner DR,: C-reactive protein elevation in patients with atrial arrhythmias: Inflammatory mechanisms and persistence of atrial fibrillation. Circulation 2001; 104: 2886-2891. (Pubitemid 33139098)
13. Chimowitz MI, Lynn MJ, Howlett-Smith H, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chaturvedi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG,: Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005; 352: 1305-1316.
14. Syed FF, Asirvatham SJ,: Left atrial appendage as a target for reducing strokes: Justifiable rationale? Safe and effective approaches? Heart Rhythm 2011; 8: 194-198.
15. Seet R, Friedman PA, Rabinstein A,: Prolonged rhythm monitoring for the detection of occult paroxysmal atrial fibrillation in ischemic stroke of unknown cause. Circulation 2011; 124: 477-486.
16. Halligan SC, Gersh BJ, Brown RD Jr, Rosales AG, Munger TM, Shen WK, Hammill SC, Friedman PA,: The natural history of lone atrial flutter. Ann Intern Med 2004; 140: 265-268.
17. Lanzarotti CJ, Olshansky B,: Thromboembolism in chronic atrial flutter: Is the risk underestimated? J Am Coll Cardiol 1997; 30: 1506-1511. (Pubitemid 27486469)
18. Biblo LA, Yuan Z, Quan KJ, Mackall JA, Rimm AA,: Risk of stroke in patients with atrial flutter. Am J Cardiol 2001; 87: 346-349, A9. (Pubitemid 32144882)
19. Schmidt H, von der Recke G, Illien S, Lewalter T, Schimpf R, Wolpert C, Becher H, Luderitz B, Omran H,: Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance. J Am Coll Cardiol 2001; 38: 778-784. (Pubitemid 32835752)
20. Capucci A, Santini M, Padeletti L, Gulizia M, Botto G, Boriani G, Ricci R, Favale S, Zolezzi F, Di Belardino N, Molon G, Drago F, Villani GQ, Mazzini E, Vimercati M, Grammatico A,: Monitored atrial fibrillation duration predicts arterial embolic events in patients suffering from bradycardia and atrial fibrillation implanted with antitachycardia pacemakers. J Am Coll Cardiol 2005; 46: 1913-1920. (Pubitemid 41579816)
21. Botto GL, Padeletti L, Santini M, Capucci A, Gulizia M, Zolezzi F, Favale S, Molon G, Ricci R, Biffi M, Russo G, Vimercati M, Corbucci G, Boriani G,: Presence and duration of atrial fibrillation detected by continuous monitoring: Crucial implications for the risk of thromboembolic events. J Cardiovasc Electrophysiol 2009; 20: 241-248.
22. Mitusch R, Garbe M, Schmucker G, Schwabe K, Stierle U, Sheikhzadeh A,: Relation of left atrial appendage function to the duration and reversibility of nonvalvular atrial fibrillation. Am J Cardiol 1995; 75: 944-947.
23. Manning WJ, Silverman DI, Katz SE, Riley MF, Doherty RM, Munson JT, Douglas PS,: Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. Am J Cardiol 1995; 75: 624-626.
24. Grimm RA, Leung DY, Black IW, Stewart WJ, Thomas JD, Klein AL,: Left atrial appendage "stunning" after spontaneous conversion of atrial fibrillation demonstrated by transesophageal Doppler echocardiography. Am Heart J 1995; 130: 174-176.
25. Wang Y, Di Biase L, Horton RP, Nguyen T, Morhanty P, Natale A,: Left atrial appendage studied by computed tomography to help planning for appendage closure device placement. J Cardiovasc Electrophysiol 2010; 21: 973-982.
26. Beinart R, Heist EK, Newell JB, Holmvang G, Ruskin JN, Mansour M,: Left atrial appendage dimensions predict the risk of stroke/TIA in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2011; 22: 10-15.
27. Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, Cybulsky I, Abouzahr L, Sawchuck C, Carroll S, Morillo C, Kleine P, Chu V, Lonn E, Connolly SJ,. Left Atrial Appendage Occlusion Study (LAAOS): Results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J 2005; 150: 288-293. (Pubitemid 41116255)
28. Kanderian AS, Gillinov AM, Pettersson GB, Blackstone E, Klein AL,: Success of surgical left atrial appendage closure: Assessment by transesophageal echocardiography. J Am College Cardiol 2008; 52: 924-929.
29. Dawson AG, Asopa S, Dunning J,: Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion? Interact Cardiovasc Thorac Surg 2010; 10: 306-311.
30. Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, Block PC, Omran H, Bartorelli AL, Della Bella P, Di Mario C, Pappone C, Casale PN, Moses JW, Poppas A, Williams DO, Meier B, Skanes A, Teirstein PS, Lesh MD, Nakai T, Bayard Y, Billinger K, Trepels T, Krumsdorf U, Sievert H,: Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: Results from the international multi-center feasibility trials. J Am Coll Cardiol 2005; 46: 9-14. (Pubitemid 40905122)
31. Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S,: Safety of percutaneous left atrial appendage closure: Results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011; 123: 417-424.
32. Jain AK, Gallagher S,: Percutaneous occlusion of the left atrial appendage in non-valvular atrial fibrillation for the prevention of thromboembolism: NICE guidance. Heart 2011; 97: 762-765.
33. Reddy VY, Neuzil P, Schuler G, Mobius-Winkler S, Sick P, Sievert H,: LAA closure using the Watchman device in patients with contraindications to warfarin: Preliminary results from teh "ASA Plavix Registry" (ASAP). J Am Coll Cardiol 2011; 57: E63.
34. Bruce CJ, Stanton CM, Asirvatham SJ, Danielsen AJ, Johnson SB, Packer DL, Friedman PA,: Percutaneous epicardial left atrial appendage closure: Intermediate-term results. J Cardiovasc Electrophysiol 2011; 22: 64-70.
35. Friedman PA, Asirvatham SJ, Dalegrave C, Kinoshita M, Danielsen AJ, Johnson SB, Hodge DO, Munger TM, Packer DL, Bruce CJ,: Percutaneous epicardial left atrial appendage closure: Preliminary results of an electrogram guided approach. J Cardiovasc Electrophysiol 2009; 20: 908-915.
36. Bartus K, Bednarek J, Myc J, Kapelak B, Sadowski J, Lelakowski J, Yakubov SJ, Lee RJ,: Feasibility of closed-chest ligation of the left atrial appendage in humans. Heart Rhythm 2011; 8: 188-193.
37. Singh SM, Dukkipati SR, d'Avila A, Doshi SK, Reddy VY,: Percutaneous left atrial appendage closure with an epicardial suture ligation approach: A prospective randomized pre-clinical feasibility study. Heart Rhythm 2010; 7: 370-376.
38. Bruce CJ, Friedman PA, Narayan O, Munger TM, Hammill SC, Packer DL, Asirvatham SJ,: Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation. J Interv Card Electrophysiols 2008; 22: 211-219.